Standex Intl SEC Filings

Standex International Corporation (SXI) insider filing shows that reporting person CANNON CHARLES H JR reported a transaction dated 08/23/2025 acquiring 599 Phantom Stock Units under the company's Management Stock Purchase Plan component of the 2018 Omnibus Incentive Plan. The units were purchased as contingent phantom stock that will vest three years after the purchase date and will be settled in the form of 599 shares of Common Stock on 08/23/2028.

The report lists the securities as directly owned following the transaction, with an exercise/settlement price of $0 for the underlying common shares. The form indicates the transaction was reported on a Form 4 with an 08/23/2025 transaction date and includes a standard explanatory note describing the contingent purchase and vesting schedule.

Standex International (SXI) reported insider purchases by Max Arets, Vice President and Chief Information Officer, under the company’s Dividend Reinvestment Plan on 08/21/2025. The Form 4 shows two small acquisitions of Common Stock: 1.178 and 0.1 shares at prices of $201.6214 and $202 respectively, increasing beneficial ownership to 1,318.532 and then 1,318.632 shares (direct ownership). The filing was signed by Alan J. Glass on 08/25/2025. The filing indicates routine reinvestment of dividends rather than open-market purchases or dispositions.

Standex International Corporation (SXI) director Robin J. Davenport reported a small acquisition of common stock on 08/21/2025 under the company’s Dividend Reinvestment Plan (DRIP). The Form 4 shows an acquisition code J(1) for 1.782 shares at a reported price of $201.538 per share, resulting in 4,059.089 shares beneficially owned following the transaction.

The filing indicates the form was filed by one reporting person and lists Davenport’s relationship to the issuer as a director. The signature block shows the form was signed by Alan J. Glass on 08/25/2025. The filer states the purchase was made pursuant to the company’s DRIP; no other transactions or derivative positions are reported.

Standex International Corp. (SXI) director Thomas J. Hansen reported a sale of common stock on 08/18/2025. The filing shows 2,992 shares sold in one or more transactions at a weighted average price of $202.6049, with individual sale prices ranging from $201.045 to $203.540. After the reported sale, the filing lists 8,439.254 shares beneficially owned by the reporting person in a direct ownership form. The Form 4 is executed on behalf of the reporting person by Alan J. Glass and signed on 08/20/2025. The filer is identified as a director of the issuer, Standex International Corporation (SXI).

Form 144 notice for Standex International Corporation (SXI) reports a proposed sale of 2,992 common shares through Fidelity Brokerage Services with an aggregate market value of $606,101.92. The filing lists 12,068,262 common shares outstanding and indicates the approximate date of sale as 08/18/2025 on the NYSE. The shares to be sold were acquired through restricted stock vesting: 1,171 shares on 09/06/2022, 1,035 shares on 10/25/2021 and 786 shares on 09/06/2021, each received as compensation. The filer reports no securities sold in the past three months and includes the standard representation about absence of undisclosed material information.

David A. Dunbar, President/CEO/Chairman and director of Standex International (SXI), reported a sale of company stock under a pre-existing 10b5-1 trading plan. On 08/13/2025 he disposed of 16,000 shares at $200 per share. The Form 4 also corrects prior reporting: 50,962 shares were gifted to a trust for the benefit of the reporting person’s spouse on 09/12/2023 and the trust’s holdings were inadvertently omitted from subsequent reports. Following the reported sale, the filing shows the reporting person (as trustee) beneficially owned 115,576 shares (indirect). The sale was executed pursuant to trading plans dated November 22, 2024, and the Form 4 was signed on 08/14/2025.

Standex International director Charles H. Cannon Jr. filed an amended Form 4 clarifying insider trading reported for May 9, 2025. The amendment corrects an earlier filing that mistakenly showed a direct sale of 2,779 common shares; the amendment states that the sale was executed by a trust rather than by Mr. Cannon personally. The transaction price shown on the form is $154.67.

The filing indicates beneficial ownership following the reported transaction includes 13,751 shares held indirectly as Trustee of a trust and a separate direct position of 2,936 shares. The amendment was submitted to remedy the original Form 4 filed May 13, 2025, and the document is signed on August 14, 2025.

Wasatch Advisors LP reports beneficial ownership of 866,830 shares of Standex International (SXI), representing 7.2% of the outstanding common stock. Wasatch discloses sole dispositive power over all 866,830 shares and sole voting power over 625,398 shares, with no shared voting or dispositive power reported.

The filing includes a certification that the securities are held in the ordinary course of business and were not acquired to change or influence control. The report classifies Wasatch as an investment adviser, making this a public notice that a registered adviser holds a material, passive stake in the company.

Standex International Corporation's Form 144 notifies a proposed sale of 16,000 shares of common stock on the NYSE through UBS Financial Services with an approximate aggregate market value of $3,200,000, and an indicated sale date of 08/13/2025. The filing lists 12,068,262 shares outstanding, which places the proposed sale at roughly 0.13% of the outstanding common stock.

The securities were acquired by the selling person through vested restricted stock units: 4,206 shares on 08/23/2023, 6,794 shares on 09/06/2023, and 5,000 shares on 09/06/2022. The form reports Nothing to Report for sales in the past three months. Several identifying fields in the filing (for example, filer CIK and issuer name/address sections) are blank or not populated in the provided text.